Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market

Reuters

08/21

Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market

Vyome Holdings Inc., a clinical-stage healthcare holding company, announced a Memorandum of Understanding (MoU) with Embryyo Technologies, a leading medical device innovation studio in India. This partnership aims to tap into the global AI-enabled medical device market by combining Vyome's industry expertise and resources with Embryyo's technological capabilities. The collaboration will focus on developing and commercializing transformative medical devices across areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome and Embryyo plan to host a global innovation forum for AI-enabled medical devices, targeting opportunities along the US-India corridor. This initiative is part of Vyome's strategic focus on pharma, AI, and medical devices to enhance healthcare standards worldwide.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250821234483) on August 21, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2561461366"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561461366\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561461366?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-21 19:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561461366","market":"fut","top_or_hot":-1,"title":"Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Vyome Holdings Inc., a clinical-stage healthcare holding company, announced a Memorandum of Understanding (MoU) with Embryyo Technologies, a leading medical device innovation studio in India. This partnership aims to tap into the global AI-enabled medical device market by combining Vyome's industry expertise and resources with Embryyo's technological capabilities. The collaboration will focus on developing and commercializing transformative medical devices across areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome and Embryyo plan to host a global innovation forum for AI-enabled medical devices, targeting opportunities along the US-India corridor. This initiative is part of Vyome's strategic focus on pharma, AI, and medical devices to enhance healthcare standards worldwide.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250821234483) on August 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-21 19:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Vyome Holdings Inc., a clinical-stage healthcare holding company, announced a Memorandum of Understanding (MoU) with Embryyo Technologies, a leading medical device innovation studio in India. This partnership aims to tap into the global AI-enabled medical device market by combining Vyome's industry expertise and resources with Embryyo's technological capabilities. The collaboration will focus on developing and commercializing transformative medical devices across areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome and Embryyo plan to host a global innovation forum for AI-enabled medical devices, targeting opportunities along the US-India corridor. This initiative is part of Vyome's strategic focus on pharma, AI, and medical devices to enhance healthcare standards worldwide.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250821234483) on August 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIND","symbol_name":"Vyome Holdings, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL2Hkxsq:1","article_id":"2561461366","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561461366","pubTimestamp":1755774069,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Vyome Holdings Inc., a clinical-stage healthcare holding company, announced a Memorandum of Understanding  with Embryyo Technologies, a leading medical device innovation studio in India. This partnership aims to tap into the global AI-enabled medical device market by combining Vyome's industry expertise and resources with Embryyo's technological capabilities. The collaboration will focus on developing and commercializing transformative medical devices across areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome and Embryyo plan to host a global innovation forum for AI-enabled medical devices, targeting opportunities along the US-India corridor. This initiative is part of Vyome's strategic focus on pharma, AI, and medical devices to enhance healthcare standards worldwide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIND":"Vyome Holdings, Inc."},"translate_title":"Vyome Holdings Inc.与Embryyo签署谅解备忘录，进军人工智能医疗设备市场","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIND":0.9},"content_text":"Vyome Holdings Inc. and Embryyo Sign MoU to Enter AI-Enabled Medical Device Market\n    \n\n        Vyome Holdings Inc., a clinical-stage healthcare holding company, announced a Memorandum of Understanding (MoU) with Embryyo Technologies, a leading medical device innovation studio in India. This partnership aims to tap into the global AI-enabled medical device market by combining Vyome's industry expertise and resources with Embryyo's technological capabilities. The collaboration will focus on developing and commercializing transformative medical devices across areas such as interventional oncology, surgery, wearables, and drug delivery. Vyome and Embryyo plan to host a global innovation forum for AI-enabled medical devices, targeting opportunities along the US-India corridor. This initiative is part of Vyome's strategic focus on pharma, AI, and medical devices to enhance healthcare standards worldwide.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250821234483) on August 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}